Intrauterine Growth Restriction

Non-branching Angiogenesis.- Angiogenic Growth Factors and their Receptors.- Effects of Oxygen on Placental Development.- Conclusions.- References.- 9. Placental Transfer and Intrauterine Growth Restriction.- Basic Concepts of Placental Transfer.- Fetal Asphyxia.- Placental Oxygen Transfer and Hypoxaemia in IUGR.- Carbon Dioxide Transfer and Hypercapnia in IUGR.- Placental Proton Transfer and Acidosis in IUGR.- Placental Glucose Transfer and Hypoglycaemia in IUGR.- Placental Amino Acid Transfer and Hypoaminoacidaemia in IUGR.- Drug Abuse, Placental Transfer and IUGR.- Conclusions.- References.- 10. Placental Pathology.- The Small for Gestational Age Infant.- Placental Size.- Gross Abnormalities.- Histological Abnormalities.- Maternal Perfusion.- Fetal Perfusion.- Cytogenetic Abnormalities.- Conclusions.- References.- Section 2 Clinical Management.- 11. Ultrasound Assessment.- The Normal Length of Pregnancy.- Assessment of Gestational Age: LMP, Ultrasound, or Conception?.- Commonly Used Ultrasound Measurements.- Precision of Ultrasound Measurements.- Appropriate Reference Ranges.- Assessment of Fetal Size.- Assessment of Fetal Growth.- Predicting the Small Infant by Biometry.- Predicting Adverse Outcome by Biometry.- Screening for Malformations.- Placental Morphology.- Amniotic Fluid.- Doppler Ultrasound Velocimetry of the Fetal Circulation.- Screening by Uterine Artery Velocimetry.- Conclusions.- References.- 12. Biochemical Markers of Fetoplacental Growth Restriction.- Alpha Fetoprotein.- Human Chorionic Gonadotrophin.- AFP, hCG and Other Risk Factors.- Other Biochemical Markers of Fetoplacental Growth Restriction.- Conclusions.- Acknowledgements.- References.- 13. Diagnosis and Management of IUGR.- Differential Diagnosis of SGA.- Is the Fetus Potentially Viable?.- Viable Early Onset "Placental IUGR".- Late Gestation "Placental IUGR" (> 35 weeks).- When is an Attempt at Vaginal Birth Futile?.- What to Do at Delivery.- Postnatal Role of the Obstetrician.- References.- 14. Management of Late Gestation IUGR: Induction or Caesarean Section?.- Outcome of Labour in the SGA Fetus.- Antepartum Tests and Outcome of Labour.- Induction of Labour.- Caesarean Section.- Conclusions.- References.- 15. Coexistent Maternal Disease and Intrauterine Growth Restriction.- The Association of Pre-eclampsia with Intrauterine Growth Restriction.- The Association Between Maternal Thrombophilias and Intrauterine Growth Restriction.- Conclusions.- References.- 16. Prevention and Treatment of IUGR.- Antenatal Care.- Antenatal Treatment.- Conclusions.- References.- 17. Management of Antepartum Fetal Death.- Obstetric Management.- Investigations.- After Delivery and Follow-up.- References.- 18. Paediatric Implications - Neonatal Complications.- Immediate Condition at Birth and Resuscitation.- Mortality.- Specific Neonatal Conditions.- The SGA Term Infant Without Risk Factors.- Metabolic Adaptation.- Necrotising Enterocolitis.- Respiratory Distress Syndrome.- Neurological Effects of Fetal Growth Restriction.- Other Problems Encountered in Preterm Infants.- Growth over the First Year.- Conclusions.- References.- 19. Paediatric Implications of IUGR with Special Reference to Cerebral Palsy.- Criteria for the Inference of IUGR.- Potential Confounders in Studies of the Association Between Paediatric Outcomes and Measures of Growth.- Studies Investigating Associations Between Paediatric Outcomes and IUGR.- Conclusions.- References.- 20. Long Term Implications for Adult Health.- The Concept of Programming During Early Development.- Fetal Growth and Adult Cardiovascular Disease.- Metabolic and Endocrine Disease.- Mechanisms Linking Fetal Programming with Adult Disease.- Effects at Different Stages of Development.- Influences Underlying Fetal Programming.- The Future.- References.- Section 3 Future Advances.- 21. Molecular Regulation of Placental Development.- Stages of Placental Development in Mice and Men.- Potential Origins of IUGR During Placental Development.- Molecular Control of Placental Development.- Finding the Molecular Targets in the IUGR Placenta.- Conclusions.- References.- 22. Towards Evidence-based Management.- The Evidence.- Effective Treatment.- Clinical Trials.- Trials of Therapy for Fetal Growth Restriction.- The GRIT Study.- Applying the Evidence to Individual Patients.- Appendix: Useful Addresses for Reviewers.- References.- 23. The Internet and Medicinev.- Medical Informatics and the Modern Physician.- The Internet.- History of the Internet.- Anatomy of the Internet.- Websites.- References.